IKCS 2020: Session 1: Multimodality Therapy For Locally Advanced RCC

preview_player
Показать описание

  1. Kidney Cancer Association
Рекомендации по теме
IKCS 2020: Session 1:01:19

IKCS 2020: Session 1: Multimodality Therapy For Locally Advanced RCC

IKCS 2020: Session 2:09:09

IKCS 2020: Session 5: Multimodality Therapy For Metastatic RCC

IKCS 2020 Session 0:40:27

IKCS 2020 Session 4: Metabolism as a Target for RCC

Tivozanib Tolerability Shows 0:01:41

Tivozanib Tolerability Shows Potential Advantage for Patients with Advanced RCC

Treating patients with 0:01:03

Treating patients with RCC in 2020 and beyond

What's the difference 0:00:41

What's the difference between cancer stage and Fuhrman grade?

Data Support Use 0:00:59

Data Support Use of Tivozanib in Patients With Advanced Renal Cell Carcinoma

Lt. renal hilar 0:01:38

Lt. renal hilar tumor

Cabozantinib as Immune 0:03:56

Cabozantinib as Immune Modulatory Therapy for Advanced RCC

Advances in Systemic 1:36:18

Advances in Systemic Therapy for Advanced & Metastatic Renal Cell Carcinoma

Neoadjuvant Axitinib and 0:04:30

Neoadjuvant Axitinib and Avelumab for High-Risk Renal Cell Carcinoma

Renal Imaging Part 0:38:55

Renal Imaging Part 1 | RadX Teaching Series

UROGRIPP: Is There 0:15:24

UROGRIPP: Is There a Role for Cyto-Reductive Nephrectomy in Metastatic RCC? - Dr. Axel Bex

Navigating Evolving Standards 1:28:18

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy Options

Wisconsin Urology - 0:07:58

Wisconsin Urology - Urologic Oncology

2020 International VHL 0:17:17

2020 International VHL Medical/Research Symposium: Axel Bex, MD, PhD